Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(14%)
Results Posted
100%(3 trials)
Terminated
2(29%)

Phase Distribution

Ph phase_2
6
86%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
6(85.7%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 26 (85.7%)
Phase 31 (14.3%)

Trials by Status

completed343%
recruiting114%
terminated229%
not_yet_recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_2

ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer

NCT06714357
not_yet_recruitingphase_2

Valproic AcId for Traumatic BRAin INjury Trial

NCT07166393
terminatedphase_2

Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine

NCT03885154
terminatedphase_2

Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

NCT01900730
completedphase_2

Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy

NCT00481013
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06714357Phase 2

ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer

Recruiting
NCT07166393Phase 2

Valproic AcId for Traumatic BRAin INjury Trial

Not Yet Recruiting
NCT03885154Phase 2

Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine

Terminated
NCT01900730Phase 2

Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

Terminated
NCT00481013Phase 2

Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy

Completed
NCT01586208Phase 3

Refractory Status Epilepticus Treatment Study

Completed
NCT00382590Phase 2

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7